Shaping the Future of Cardiac Wellness: Exploring Revolutionary Approaches in Disease Management and Prevention

T. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, Yuliang Wang, Ayman El Baz, N. Elarabany, Ahmed A. Khalil
{"title":"Shaping the Future of Cardiac Wellness: Exploring Revolutionary Approaches in Disease Management and Prevention","authors":"T. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, Yuliang Wang, Ayman El Baz, N. Elarabany, Ahmed A. Khalil","doi":"10.33696/cardiology.5.048","DOIUrl":null,"url":null,"abstract":"Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide. Effective prevention and management strategies are essential to reduce the burden of CVDs. This review summarizes recent advances in the prevention and management of CVDs. In terms of prevention, lifestyle modifications, such as diet, exercise, and smoking cessation, remain important strategies. Pharmacological interventions, including statins, antiplatelet agents, and antihypertensive medications, have also shown benefits. Innovative approaches, such as genetic testing and risk stratification, targeted prevention strategies, and the use of mobile health technology, are being explored. In terms of management, acute management strategies, such as reperfusion therapy for myocardial infarction, acute heart failure management, and stroke management, have improved outcomes. Chronic management strategies, including medical therapy for heart failure, arrhythmia management, and device therapy for heart failure, have also shown benefits. Innovative approaches, such as precision medicine and personalized treatment, the use of artificial intelligence in diagnosis and treatment, and advances in traditional Chinese and regenerative medicine, are being investigated. While recent advances in the prevention and management of CVDs are promising, challenges remain in implementing these strategies, including cost-effectiveness, access to care, and resistance to change in clinical practice. Continued research and innovation are essential to reduce the burden of CVDs and improve patient outcomes.","PeriodicalId":15510,"journal":{"name":"Journal of Clinical Cardiology","volume":"14 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.33696/cardiology.5.048","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide. Effective prevention and management strategies are essential to reduce the burden of CVDs. This review summarizes recent advances in the prevention and management of CVDs. In terms of prevention, lifestyle modifications, such as diet, exercise, and smoking cessation, remain important strategies. Pharmacological interventions, including statins, antiplatelet agents, and antihypertensive medications, have also shown benefits. Innovative approaches, such as genetic testing and risk stratification, targeted prevention strategies, and the use of mobile health technology, are being explored. In terms of management, acute management strategies, such as reperfusion therapy for myocardial infarction, acute heart failure management, and stroke management, have improved outcomes. Chronic management strategies, including medical therapy for heart failure, arrhythmia management, and device therapy for heart failure, have also shown benefits. Innovative approaches, such as precision medicine and personalized treatment, the use of artificial intelligence in diagnosis and treatment, and advances in traditional Chinese and regenerative medicine, are being investigated. While recent advances in the prevention and management of CVDs are promising, challenges remain in implementing these strategies, including cost-effectiveness, access to care, and resistance to change in clinical practice. Continued research and innovation are essential to reduce the burden of CVDs and improve patient outcomes.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
塑造心脏健康的未来:探索疾病管理和预防的革命性方法
心血管疾病(CVDs)仍然是全球发病率和死亡率的主要原因。有效的预防和管理策略对于减轻心血管疾病的负担至关重要。本综述总结了心血管疾病预防和管理方面的最新进展。在预防方面,改变饮食、运动和戒烟等生活方式仍然是重要的策略。药物干预,包括他汀类药物、抗血小板药物和降压药物,也显示出其益处。目前正在探索创新方法,如基因检测和风险分层、有针对性的预防策略以及使用移动医疗技术。在管理方面,心肌梗死再灌注治疗、急性心力衰竭管理和中风管理等急性管理策略改善了治疗效果。慢性管理策略,包括心力衰竭的药物治疗、心律失常管理和心力衰竭的器械治疗,也显示出了效益。精准医学和个性化治疗、人工智能在诊断和治疗中的应用以及传统中医和再生医学的发展等创新方法正在研究之中。虽然最近在心血管疾病预防和管理方面取得的进展令人充满希望,但在实施这些策略方面仍存在挑战,包括成本效益、医疗服务的可及性以及临床实践变革的阻力。持续的研究和创新对于减轻心血管疾病负担和改善患者预后至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
In-Stent Restenosis: Achilles’ Heel of Post-PCI Era Shaping the Future of Cardiac Wellness: Exploring Revolutionary Approaches in Disease Management and Prevention COVID Pneumonia, Non-ST Elevation Myocardial Infarction, QRS Fragmentation, and Electrocardiographic Wavy Triple or Yasser's Sign in Hodgkin Lymphoma-Prognostic Influence and Serious Outcome EASI Monitoring: An Alternative to Conventional Electrocardiography in the Recording of Ventricular Tachycardia The Use of CHA2DS2-VASc Score to Predict Functional Outcomes of Mechanical Thrombectomy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1